He wrote that the company has “some reservations” on the intradermal approach, “due to the very limited safety data available (<200 people), the higher reactogenicity compared to the JYNNEOS standard dose and route (subcutaneous ), and the fact that there was a relatively high percentage of subjects (20%) that failed to receive the second vaccination during a controlled clinical study.” Califf about the plan, according to The Washington Post. Health and Human Services Secretary Xavier Becerra and FDA Commissioner Robert M. There is also not much data available yet on which jurisdictions are using the new strategy.ĬEO Paul Chaplin sent a letter to U.S. Food and Drug Administration approved an emergency use authorization earlier this month to switch from giving the vaccine subcutaneously, the way most people are used to receiving a vaccine, to intradermally, or just below the skin.īavarian Nordic, the only company that makes the Jynneos vaccine, has raised concerns about the FDA decision, as have some local and state health departments. WASHINGTON - Federal public health officials said Thursday they are working with state and local health departments to boost messaging and vaccinations for those most likely to contract monkeypox, including at large-scale events.īut Biden administration officials at a press briefing also struggled to explain differing statements about how the vaccines should be administered, a crucial part of the White House strategy.
0 kommentar(er)
